awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38843265-13D9C2D4-B229-4DB4-9761-8CD60C3660DD
Q38843265-13D9C2D4-B229-4DB4-9761-8CD60C3660DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38843265-13D9C2D4-B229-4DB4-9761-8CD60C3660DD
Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy.
P2860
Q38843265-13D9C2D4-B229-4DB4-9761-8CD60C3660DD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38843265-13D9C2D4-B229-4DB4-9761-8CD60C3660DD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
122d19b473532b0c747deac685a823c4cde062ca
P2860
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency